Cervical Cancer Research Articles

Efficacy and safety of trastuzumab deruxtecan among patients with HER2-expressing solid tumors: Biomarker and subgroup analyses from the cervical, endometrial, and ovarian cancer cohorts of the DESTINY-PanTumor02 study

Efficacy and safety of trastuzumab deruxtecan among patients with HER2-expressing solid tumors: Biomarker and subgroup analyses from the cervical, endometrial, and ovarian cancer cohorts of the DESTINY-PanTumor02 study

Bankruptcy incidence rates among Massachusetts cancer patients are highest among those with cervical and uterine cancers

Bankruptcy incidence rates among Massachusetts cancer patients are highest among those with cervical and uterine cancers

Time toxicity associated with immunotherapy-related adverse events in cervical and endometrial cancer patients

Time toxicity associated with immunotherapy-related adverse events in cervical and endometrial cancer patients

Immune-related adverse events in metastatic/recurrent cervical and vulvar cancer associated with a significant survival advantage

Immune-related adverse events in metastatic/recurrent cervical and vulvar cancer associated with a significant survival advantage

The cervical and tumor-associated microbiome among Botswanan women with HIV diagnosed with high-grade cervical dysplasia and squamous cell carcinoma of the cervix

The cervical and tumor-associated microbiome among Botswanan women with HIV diagnosed with high-grade cervical dysplasia and squamous cell carcinoma of the cervix

A surgery-based comprehensive treatment improved prognosis among patients with stage IIIC cervical squamous carcinoma: A single center retrospective study

A surgery-based comprehensive treatment improved prognosis among patients with stage IIIC cervical squamous carcinoma: A single center retrospective study

Clearance of high-risk HPV after large loop excision of the transformation zone of early-stage invasive cervical cancer or adenocarcinoma in situ is highly correlated with the absence of residual cancer

Clearance of high-risk HPV after large loop excision of the transformation zone of early-stage invasive cervical cancer or adenocarcinoma in situ is highly correlated with the absence of residual cancer

Learning from the Indian National Family Health Survey to assess population based oral, cervix and breast cancer screening in low-and-middle income countries

Learning from the Indian National Family Health Survey to assess population based oral, cervix and breast cancer screening in low-and-middle income countries

Practice patterns in the treatment of small cell carcinoma of the cervix: Analysis of a Canadian multidisciplinary survey

Practice patterns in the treatment of small cell carcinoma of the cervix: Analysis of a Canadian multidisciplinary survey

Photodynamic therapy in the prevention of HPV-induced recurrences of precancer and initial cancer of the cervix

Photodynamic therapy in the prevention of HPV-induced recurrences of precancer and initial cancer of the cervix

Nutritional status and its impact on cervical cancer patients treated with immunotherapy

Nutritional status and its impact on cervical cancer patients treated with immunotherapy

Maintenance bevacizumab following chemotherapy improves survival among patients with advanced and recurrent cervical cancer

Maintenance bevacizumab following chemotherapy improves survival among patients with advanced and recurrent cervical cancer

Postoperative voiding dysfunction by void trial methodology following radical hysterectomy for cervical cancer

Postoperative voiding dysfunction by void trial methodology following radical hysterectomy for cervical cancer

Chemoradiotherapy response and the tumor microenvironment in a novel immunocompetent mouse model of cervical cancer

Chemoradiotherapy response and the tumor microenvironment in a novel immunocompetent mouse model of cervical cancer

Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer: Japanese Gynecologic Oncology Group study

Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer: Japanese Gynecologic Oncology Group study

Weakly supervised deep learning-based prognostic model for AI-assisted prospective clinical investigation of cervical cancer

Weakly supervised deep learning-based prognostic model for AI-assisted prospective clinical investigation of cervical cancer

Evaluation of the somatic and immunologic landscapes of primary and metastatic cervical cancer to better inform future clinical trial development

Evaluation of the somatic and immunologic landscapes of primary and metastatic cervical cancer to better inform future clinical trial development

Overall survival with camrelizumab plus famitinib versus camrelizumab alone and investigator's choice of chemotherapy for recurrent or metastatic cervical cancer

Overall survival with camrelizumab plus famitinib versus camrelizumab alone and investigator's choice of chemotherapy for recurrent or metastatic cervical cancer

A prospective study on the application of para-aortic lymph node metastasis prediction model in locally advanced cervical cancer and its effect on prognosis (CQGOG-0109)

A prospective study on the application of para-aortic lymph node metastasis prediction model in locally advanced cervical cancer and its effect on prognosis (CQGOG-0109)

PO0244: The Feasibility of Transvaginal Interstitial Brachytherapy for Cervical Cancer with Uterosacral Ligament Invasion

PO0244: The Feasibility of Transvaginal Interstitial Brachytherapy for Cervical Cancer with Uterosacral Ligament Invasion